AstraZeneca and Bristol Myers Squibb Explore $400 Billion Merger, According to Financial Times
AstraZeneca is exploring a potential merger with Bristol Myers Squibb, which could create a combined entity valued at approximately $400 billion, marking one of the largest mergers in history.